| RE49948 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2024-04-30 |
|
| 11174273 |
Quinazoline analogs as receptor tyrosine kinase inhibitors |
George T. Topalov, Joseph P. Lyssikatos, Alexandre Joseph Buckmelter, Qian Zhao |
2021-11-16 |
|
| 10807948 |
Aromatic compounds and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2020-10-20 |
|
| 10786480 |
Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof |
John A. Josey, Guangzhou Han |
2020-09-29 |
|
| 10597366 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2020-03-24 |
|
| 10335388 |
Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
John A. Josey, Guangzhou Han |
2019-07-02 |
|
| 10278942 |
Compositions for use in treating pulmonary arterial hypertension |
John A. Josey, Xinlin Du, Barry Goggin |
2019-05-07 |
|
| 10221194 |
Quinazoline analogs as receptor tyrosine kinase inhibitors |
Joseph P. Lyssikatos, George T. Topalov, Alexandre Joseph Buckmelter, Qian Zhao |
2019-03-05 |
$52,115,000 |
| 10144711 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2018-12-04 |
|
| 10040767 |
Benzimidazole derivatives and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +3 more |
2018-08-07 |
|
| 10017482 |
Mitotic kinesin inhibitors and methods of use thereof |
Jeremy Hans, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher, Ellen Laird +2 more |
2018-07-10 |
$44,836,000 |
| 9969689 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2018-05-15 |
|
| 9969727 |
Pyrrolopyridines as kinase inhibitors |
Yvan Le Huerou, James F. Blake, Indrani W. Gunawardana, Peter Mohr, Bin Wang +2 more |
2018-05-15 |
$20,875,000 |
| 9908845 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2018-03-06 |
|
| 9896418 |
Aryl ethers and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2018-02-20 |
|
| 9884843 |
Cyclic sulfone and sulfoximine analogs and uses thereof |
Darryl David Dixon, Jonas Grina, John A. Josey, James P. Rizzi, Stephen T. Schlachter +4 more |
2018-02-06 |
|
| 9676791 |
Quinazoline analogs as receptor tyrosine kinase inhibitors |
George T. Topalov, Joseph P. Lyssikatos, Alexandre Joseph Buckmelter, Qian Zhao |
2017-06-13 |
$10,834,000 |
| 9499503 |
Mitotic kinesin inhibitors and methods of use thereof |
Jeremy Hans, Qian Zhao, Joseph P. Lyssikatos, Thomas D. Aicher, Ellen Laird +2 more |
2016-11-22 |
$32,720,000 |
| 9365568 |
Pyrrolopyridines as kinase inhibitors |
Yvan Le Huerou, James F. Blake, Indrani W. Gunawardana, Peter Mohr, Bin Wang +2 more |
2016-06-14 |
$5,790,000 |
| 9359340 |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
Ian S. Mitchell, James F. Blake, Rui Xu, Nicholas C. Kallan, Dengming Xiao +9 more |
2016-06-07 |
$6,197,000 |
| 9346805 |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
Anna L. Banka, Josef R. Bencsik, James F. Blake, Kin Chiu Fong, Martin F. Hentemann +5 more |
2016-05-24 |
$5,944,000 |
| 9328091 |
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors |
Anna L. Leivers, Josef R. Bencsik, James F. Blake, Martin F. Hentemann, Nicholas C. Kallan +5 more |
2016-05-03 |
|
| 9221841 |
Mitotic kinesin inhibitors and methods of use thereof |
Jeremy Hans, Qian Zhao, Shelley Allen, Ellen Laird, Joseph P. Lyssikatos +4 more |
2015-12-29 |
$9,152,000 |
| 9187462 |
Substituted quinazolines as serine/threonine kinase inhibitors |
James F. Blake, Huifen Chen, Mark Joseph Chicarelli, Jason Demeese, Rustam Ferdinand Garrey +8 more |
2015-11-17 |
$8,702,000 |
| 9133187 |
Serine/threonine kinase inhibitors |
James F. Blake, Huifen Chen, Mark Joseph Chicarelli, Jason Demeese, Rustam Ferdinand Garrey +11 more |
2015-09-15 |
$12,297,000 |
